OSE IMMUNOTHERAPEUTICS |
Market Closed -
Other stock markets
|
After market 20:02:21 | |||
| 7.45 EUR | +3.19% |
|
7.445 | -0.07% |
| 04-17 | OSE: licensing agreement with AbbVie enters into force | CF |
| 04-17 | OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Other Biotechnology & Medical Research | +3.19% | +11.86% | +74.07% | +103.27% | +96.05% | 168M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- OSE Stock
- Charts OSE Immunotherapeutics
- Comparison Chart
